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A B S T R A C T
F1FO ATP synthase, also known as complex V, is a key enzyme of mitochondrial energy metabolism that can
synthesize and hydrolyze ATP. It is not known whether the ATP synthase and ATPase function are correlated
with a different spatio-temporal organisation of the enzyme. In order to analyze this, we tracked and localized
single ATP synthase molecules in situ using live cell microscopy. Under normal conditions, complex V was mainly
restricted to cristae indicated by orthogonal trajectories along the cristae membranes. In addition confined
trajectories that are quasi immobile exist. By inhibiting glycolysis with 2-DG, the activity and mobility of
complex V was altered. The distinct cristae-related orthogonal trajectories of complex V were obliterated.
Moreover, a mobile subpopulation of complex V was found in the inner boundary membrane. The observed
changes in the ratio of dimeric/monomeric complex V, respectively less mobile/more mobile complex V and its
activity changes were reversible. In IF1-KO cells, in which ATP hydrolysis is not inhibited by IF1, complex V was
more mobile, while inhibition of ATP hydrolysis by BMS-199264 reduced the mobility of complex V. Taken
together, these data support the existence of different subpopulations of complex V, ATP synthase and ATP
hydrolase, the latter with higher mobility and probably not prevailing at the cristae edges. Obviously, complex V
reacts quickly and reversibly to metabolic conditions, not only by functional, but also by spatial and structural
reorganization.
1. Introduction
In respiring cells, ATP is mainly provided by oxidative phosphor-
ylation (OXPHOS) involving five membrane protein complexes (CI-CV)
in the inner mitochondrial membrane. Their joined task is to oxidize
NADH/H+ (complex I) and FADH2 (complex II) to generate a proton
motive force across the inner membrane (complexes I, III, IV) and to
synthesize ATP (F1FO ATP synthase, complex V). Tumor cells, often
used in research, usually have a reduced oxidative metabolism and
switch to glycolytic energy metabolism – a phenomenon known as the
Warburg effect [1,2]. By changing the sugar supply, this can be re-
versed [3]. Morphology and internal architecture of mitochondria are
responsive to mitochondrial function [4–7]. The mitochondrial ultra-
structure is modulated by several inner membrane proteins, including
the Optic atrophy 1 protein OPA1 [8], compounds of the MICOS
complex at the cristae junctions [9–11], and F1FO ATP synthase [12].
Moreover, new studies suggest that these main players are functionally
coupled, e.g. high OPA1 levels [13] and Mic10/Mic27 [14] apparently
stabilize complex V oligomerization. Habitually, F1FO ATP synthase
assembles into rows of dimers at the small rims of lamellar or tubular
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cristae [15,16]. Analysis of distances between complex V by 3D-STORM
superresolution suggests that stress conditions affecting respiration also
alter complex V dimer organization [17,18]. These observations imply
that complex V exhibits specific spatio-temporal dynamics which allows
such re-organization. Indeed, single particle tracking and FRAP studies
have shown that the complex V is in principal diffusive in the inner
membrane [19–21], which suggest that the assembly of complex V into
rows of dimers is reversible.
The purpose of this study was to monitor the underlying dynamics
of ATP synthase/ATPase organization in response to metabolic
switches. We monitored the spatio-temporal organization of complex V
with a particular focus on its mobility in the inner membrane. To induce
a short-term metabolic switch, the enzyme Hexokinase, which has a key
function at the junction between glycolysis and respiration, was in-
hibited by the non-fermentable sugar 2-Deoxy-D-glucose (2-DG)
[22,23]. This resulted in an intermediate depletion of substrate for the
respiratory chain, measurable by a decrease in extracellular acidifica-
tion rate as well as maximal and spare oxygen consumption rate.
However, it seems that this decrease did not result in decreased ATP
synthesis in mitochondria. On contrary, we found an increased mi-
tochondrial ATP production rate – correlating with a lower mitochon-
drial membrane potential ΔΨm. As inhibitor studies suggested, ATP
hydrolysis - in addition to ATP synthesis - apparently took place before
2-DG treatment. To dissect whether ATPase Inhibitory Factor 1 (IF1)
and spatial separation of ATP synthesis and hydrolysis might be a clue,
we determined the localization and mobility of complex V molecules
under different conditions. Therefore, we fluorescence-labeled complex
V and recorded its localization and dynamics on the single molecule
level by means of Tracking and Localization Microscopy (TALM)
[19,24]. Trajectories of F1FO ATP synthase particles were obtained from
single particle tracking experiments with the Multiple-Target Tracing
Algorithm (MTT) [25]. We found that increased ATP synthesis in 2-DG
treated cells was accompanied by a slight decrease of the dimer/
monomer ratio and a narrowing of cristae. In addition, the complex V
showed a different localization pattern in cristae, with decreased dif-
fusion coefficients. When ATP synthesis decreased again, complex V
reorganized and showed the same localization and mobility pattern as
before. Furthermore, cristae widened again. Moreover, complex V dif-
fusion was decreased upon chemically inhibition of ATP hydrolysis, but
increased under conditions where the factor for physiological inhibition
of ATP hydrolysis was knocked out. Thus, our data show that spatio-
temporal organization of complex V is determined by the specific me-
tabolic setting, which here was given as a reversible inhibition of gly-
colysis.
2. Materials and methods
2.1. Cell culture and labeling
Stable transfected HeLa cells expressing SU γ-HaloTag® were culti-
vated in Minimal Essential Medium Earle's Salt (5.6mM glucose+ L-
glutamine) supplemented with 10% FBS (Fetal bovine serum), 1%
HEPES and 1% NEAA (non-essential amino acids) at 37 °C and 5% CO2.
When confluence was reached, cells were split using 1mL Trypsin/
EDTA for 5min at 37 °C (and 5% CO2). Labeling and preparation of
single molecule studies is described in detail elsewhere [19,24].
2.2. Metabolic studies
Oxygen consumption rates (OCR) and extracellular acidification
rates (ECAR) of intact HeLa cells were recorded with the Seahorse
XFe96 Extracellular Flux Analyzer (Agilent Technologies). 25.000 cells
were seeded per well of a 96-well XF cell culture microplate 24 h before
the experiment. Before loading into the XFe Analyzer, control cells were
washed with XF base medium adjusted to pH 7.4 (Minimal DMEM,
0mM Glucose, 102353-100 from Agilent), placed in fresh XF base
medium pH 7.4 with supplements (1mM pyruvate, 2 mM L-glutamine,
and 5.6mM D-glucose) and shortly incubated at 37 °C. Supplements
were from Carl Roth GmbH+Co. KG. To inhibit glycolysis, 30mM 2-
Deoxy-D-glucose (2-DG, Sigma Aldrich) was added to the 5.6 mM
glucose MEM and XF base media with supplements. After recording
resting respiration in the analyzer, a mitochondrial stress test was
performed. Therefore, the following chemicals from Seahorse
Biosciences were added sequentially to the cells: oligomycin (1 μM) to
inhibit the ATP synthase; trifluoromethoxy carbonylcyanide phe-
nylhydrazone (FCCP, 0.5 μM) an uncoupler of respiration and ATP
synthesis, and inhibitors for complex I (rotenone; 0.5 μM) and complex
III (antimycin A; 0.5 μM). In each experiment, three time points with a
6min interval were recorded for the basal oxygen consumption rate
(OCR). In a second experiment analyzing mitochondrial fuel usage, the
following chemicals from Agilent (former Seahorse Biosciences) were
added sequentially to the cells: UK5099 (2-Cyano-3-(1-phenyl-1H-
indol-3-yl)-2-propenoic acid, 2 μM), to inhibit the glucose oxidation
pathway by blocking the mitochondrial pyruvate carrier (MPC); BPTES
(Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide, 3 μM),
an allosteric inhibitor of glutaminase (GLS1), to inhibit the glutamine
oxidation pathway; Etomoxir (4 μM), to inhibit long chain fatty acid
oxidation by blocking the carnitine palmitoyl-transferase 1A (CPT1A).
By subsequent addition of the inhibitors of metabolic pathways (glu-
cose, GLC; glutamine, GLU and fatty acid, FA catabolism), fuel de-
pendency was determined. Three measurements were conducted for the
resting OCR, five after the first injection and five after the second in-
jection with a 2-min interval of recording followed by 2min of mixing
and 2min of incubation for each measurement. In a third experiment
referred to as ATP rate assay, XF base medium pH 7.4 with additional
supplementation of 5mM HEPES was used. The assays to dissect mi-
tochondrial from glycolytic ATP synthesis rates follows suggestions
made by Mookerjee and co-workers [41]. Injections: Oligomycin
(1.5 μM) to inhibit the ATP synthase; inhibitors for complex I (rotenone;
0.5 μM) and complex III (antimycin A; 0.5 μM). Inhibitors were pur-
chased from Agilent (Agilent Seahorse XF Real-Time ATP Rate Assay Kit
103592-100). Agilent Seahorse XF technology measures the flux of both
H+ production (ECAR) and O2 consumption (OCR), simultaneously. By
obtaining OCR and ECAR data under basal conditions and after serial
addition of mitochondrial inhibitors (oligomycin and rotenone/anti-
mycin A), total cellular ATP Production Rates and pathway-specific
mitoATP and glycoATP Production Rates can be measured. The series of
calculations used to transform the OCR and ECAR data to ATP Pro-
duction Rates is performed using the Agilent Seahorse XF Real-Time
ATP Rate Assay Report Generator, described in the according user
guide. Briefly: Glycolytic ATP Production Rate (pmol ATP/
min)= glycoPER (pmol H+/min) is associated with the conversion of
glucose to lactate in the glycolytic pathway; Mitochondrial ATP pro-
duction rate: OCRATP (pmol O2/min)=OCR (pmol O2/min) - OCROligo
(pmol O2/min) is associated with oxidative phosphorylation in the
mitochondria. Total ATP production rate: Glycolytic ATP Production
Rate+Mitochondrial ATP Production Rate. Cell counting: Cell number
per well was measured after ATP rate assay performance by counting
fluorescently labeled nuclei from images captured by Cytation 1
(BioTek). Therefore, cells were stained with 2 μg/mL Hoechst 33342
(Sigma) and the nuclear images were captured using a 4× lens with a
DAPI filter. Cells (the individual nuclei) were counted by BioTek Cy-
tation 1 using the XF Cell Imaging and Counting software2 and data
was normalized in Wave software.
2.3. Generation of IF1-KO cell lines
The IF1-knockout cells were manufactured using the CRISPR/Cas
technique. The first step was to find the appropriate targeting sequence
for crRNA in the vicinity of the START codon. The crRNA was cloned
into the pSpCas9(BB)-2A-GFP (PX458) vector (Addgene). Thus, the
resulting vector contained both sgRNA and Cas9 nuclease. To enable
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selection with Puromycin, the pac gene was inserted at the cutting site.
For this purpose, a construct was cloned with homologous arms to the
right and left of the place where Cas9 is to be cut with the pac-gen in
between. HeLa cells were cotransfected with both constructs and
transformed cells were selected by Puromycin treatment. Positive
clones were isolated and the IF1 knockdown tested by qPCR.
2.4. ROS measurements
Before staining, culture medium was exchanged to PBS (phosphate
buffered saline w/o Ca2+ and Mg2+) plus 1% FBS (fetal bovine serum).
For ROS detection, cells were stained with 2.5 nM of CellROX™ Deep
Red (λex/em~644/665 nm) in PBS for 30min. After washing twice with
PBS, flow cytometry analysis was performed with the adequate laser
and band pass filter (exc. 660/10 nm, em. 690/50 nm). For the time
course of ROS levels in dependency on 2-DG application, microscopic
analysis was conducted (cLSM, 63× objective). HeLa cells that stable
expressed a matrix-targeted GFP were stained with the ROS sensitive
dye MitoTracker®CM-H2XRos Red (200 nm for 30min) and then wa-
shed twice with PBS. MitoTracker Red CM-H2XRos is a reduced, non-
fluorescent version of MitoTracker Red (M-7512, Thermofisher) that
fluoresces upon oxidation. The emission of MitoTracker Red CM-
H2XRos was set to 600–700 nm (exc. 579 nm). For imaging, medium
without phenol red was used. Before 2-DG application (30mM), cells
were imaged (t=0min). Every 5min, several images were taken at
different positions to minimize photobleaching effects. N=3 technical
replicates. The fluorescence intensities were analyzed with ImageJ
(MacBiophotonics). The ROS signal was normalized to the mt-GFP
signal.
2.5. Measurement of mitochondrial membrane potential
Mitochondrial membrane potential ΔΨm was measured using the
ΔΨm sensitive dye tetramethylrhodamine ethyl ester (TMRE, 7 nM)
[26]. The dye was excited at 561 nm, and the emission recorded be-
tween 600 and 700 nm at a fluorescence microscope. For normalization
on the mitochondrial mass, mitochondria in addition were stained with
MitoTracker™ Green (MTG, 100 nM). The fluorescence of MTG is sup-
posed to be membrane potential independent [27]. MTG was excited at
488 nm, emission was recorded between 510 and 540 nm. Z-stacks of 7
slices (step size of 360 nm) were recorded. The fluorescence intensity
was analyzed with ImageJ (MacBiophotonics). The ratio of the TMRE/
MTG signal indicates the relative value of the ΔΨm.
2.6. Fluorescence microscopy
Fluorescence imaging was carried out with confocal laser scanning
microscope (Leica TCS SP8 SMD) equipped with a 63× water objective
(N.A. 1.2) and a tunable white light laser. HyD's with GaASP photo-
cathodes were used as detectors. Measurements were performed at
37 °C and 5% CO2. For determination of fluorescence intensities of
fluorescent dyes specifically accumulating in mitochondrial compart-
ments, mean grey values of the whole mitochondrial network are
measured after automatic clustering-based image thresholding by ap-
plication of the Otsu's thresholding in the open source Fiji program.
2.7. ATP determination
Relative ATP was determined by using a FRET sensor composed of
the ε-subunit of complex V from Bacillus spec. sandwiched between
Clover and mRuby2 (Clover-ATeam-mRuby2), modified from the ori-
ginal ATeam [28]. FRET was determined via fluorescence lifetime (τ)
decrease of the donor with increasing ATP. τ was determined in the
time domain with a time correlated single photon counting device
(Piqoquant/Leica) docked to the cLSM. Clover was excited at 488 nm
with a pulsed white light laser (40MHz), emission was recorded from
520 to 560 nm using a BS560, Bandpass filter I BP500-550. For the
decay histograms, at least 1000 photons were collected per pixel.
2.8. Single molecule tracking and localization microscopy
Single molecule tracking and localization was performed at a room
temperature with an inverted microscope (Nikon, Eclipse TE2000)
equipped with a TIRF condenser, an oil immersion objective designed
for TIRF (100× oil/N.A. 1.49/0.12 Apochromat, Nikon), an EMCCD
camera (Evolve™512, Photometrics, 512× 512 pixel imaging array,
16 μm×16 μm pixel area). To fulfil the Nyquist-oversampling, a 1.5x
magnitude focussing lens was used. A quad line beam splitter (zt405/
488/561/633–640) was mounted in combination with an emission
quadband filter (HC 446 nm/523 nm/600 nm/677 nm). A 561 nm laser
(Melles Griot, 20mW, DPSS) was coupled into the device via a single-
mode glass fiber (FC/PC). The measurements were performed as de-
scribed before [29]. In short, HeLa cells stable transfected with F1FO
ATP synthase subunit ɣ fused C-terminally to a HaloTag were post-
translationally labeled with TMRHTL (1 nM) for 20min, washed twice in
PBS and once in medium without phenol red before imaging. Assembly
and correct intramitochondrial localization were shown earlier with
constructs where similar sized EGFP and pHluorin, respectively, were
genetically fused to the same position in SU γ as exchange of by the
HaloTag7 [30,31]. The TMRHTL concentration was set for sub-stoi-
chiometric labeling and low enough to visualize single molecule sig-
nals. The incident angle was set to achieve a highly inclined laminated
optical light sheet [32]. Usually, 3000 frames were recorded. Frame
rates were 33 Hz and 50 Hz, respectively. Individual signals with a
signal to noise ratio above 5 were fitted with a 2D Gaussian fit for lo-
calizing molecules. From all frames, a cumulative localization map was
generated after movement of mitochondria during the recording time
was excluded. For generating trajectory maps, single molecules in
subsequent frames were connected when the following criteria were
matched: they must have been within a radius of maximal 2 px (pixel
size 107 nm) and the intensity distribution profile must have been
identical. Only trajectories with a minimum duration of 160ms were
analyzed.
2.9. Theoretical background
Single fluorescent molecules, whose size is below the diffraction
limit, project a three-dimensional diffraction pattern onto the image
plane, which is defined as the point spread function (PSF). The PSF can
be calculated by Abbe's law and used to localize single emitters by a 2D
Gaussian fit [33–35]:
= =d
2NA n2 sin( ) (1)
with d being the diameter of the PSF, λ as the wavelength of the emitted
light and NA being the numerical aperture of the microscope's objec-
tive. The numerical aperture describes the light gathering capability of
an objective and depends on the refractive index n of the medium in
which the lens is used and the half angular aperture of the objective θ.
The “full width at half maximum” (FWHM) criterion is used to describe
a PSF, whereby FWHM is the width at 50% of the intensity maximum.
For TMR (λem.= 582 nm) and an objective with NA of 1.49, the PSF
diameter is approximately 390 nm.
According to the Rayleigh criterion, the resolution of the system is:
= =r
2NA n
1.22 0,61
sin( ) (2)
where r is the minimal distance between the two objects. n is the re-
fractive index of the medium between the objective and sample, λ is the
wavelength of the emitted light, θ is the half angular aperture of the
objective and NA is the numerical aperture of the microscope objective.
Practically, this means that two separate light points can just be
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distinguished if the intensity maximum of the first point coincides with
the first intensity minimum of the second point. Here, the theoretical
resolution is ~240 nm. The pixel size was 106.7 nm for an EMCCD
camera (512×512 px chip) with a pixel area of 16 μm×16 μm, thus
fulfilling the Nyquist-Shannon sampling theorem which demands a
2fold oversampling rate for the desired spatial resolution. In order to
probe the spatio-temporal behavior of F1FO ATP synthase, the multi-
target tracer was used [25]. The first step of single-particle tracking
(SPT) involves the localization of the particle by a 2D Gaussian fit. The
accuracy of this localization highly depends on the occurrence of dis-
crete signals, the pixel size of the EMCCD/CMOS camera and the
photon emission of the molecule as well as the background noise:
= + +s
N
a /12
N
8 s b
a Nµi
i
2 2
i
4 2
2 2 (3)
where σ is the standard error of the mean value of photon distribution,
N is the number of gathered photons, a is the pixel size of the EMCCD/
CMOS detector, b is the standard deviation of the background and si is
the standard deviation in dimension i, with i being either x or y di-
mension.
2.10. Single molecule localization and tracking
Single molecules are recorded over several frames and then are lo-
calized by a 2D Gaussian mask. The multiple-target tracing algorithm
(MTT) [25] is used to generate trajectories. To obtain diffusion data, the
mean square displacement is determined (MSD) and the diffusion
coefficient is calculated according to:= +nr 2 4D t 42 2 (4)
=D r
n t
4
2 4
,
2 2
(5)
where r2 is the MSD, D is the lateral diffusion coefficient, Δt is the lag
time, n is the dimension and ε is the localization error. The exponent α
is a factor that distinguishes modes of diffusion, with α < 1 for
anomalous diffusion. Anomalous diffusion is expected when the
movement of particles is restricted by structural constraints such as
physical obstacles or inclusion in micro-compartments. Further details
are found in Appelhans et al. [29].
2.11. Transmission electron microscopy
For transmission electron microscopy (TEM) HeLa cells from the
different conditions were fixed for 2 h at room temperature (RT) in
2.5% glutaraldehyde (Sciences Services, Germany) and in 0.1M caco-
dylate buffer pH 7.4 (Sciences Services, Germany), subsequently wa-
shed in 0.1M cacodylate buffer pH 7.4, post-fixed for 2 h at RT in 1%
osmium tetroxide/0.8% potassium ferrocyanide in 0.1M cacodylate
buffer pH 7.4, dehydrated stepwise in a graded ethanol series and em-
bedded in Epon 812 (Fluka, Buchs, Switzerland). Ultrathin sections
(70 nm, ultramicrotome EM UC7, Leica, Wetzlar, Germany) were
afterwards stained for 30min with 1% uranyl acetate (Leica, Germany)
and 20min in 3% lead citrate (Leica, Germany). TEM images were
acquired with a 200 kV transmission electron microscope (JEM2100-
Plus, Jeol Japan). The cristae width was determined as following: TEM
images were inverted. Line plots were perpendicularly placed to the
length of cristae (ImageJ™). The line plot intensity profiles showed two
peaks corresponding to the intensity of the negative stained mem-
branes. The distance between the peaks was taken as cristae width. Per
crista, two to three line plots were drawn for the determination of the
crista width.
2.12. Blue Native page electrophoresis assays
Mitochondria from the indicated cell lines were isolated as follows.
HeLa cells were cultured in Minimum Essential Medium Eagle (MEM)
supplemented with 10% fetal calf serum (FCS); 1% non-essential amino
acids (NEAS), 1% HEPES, and 1% glutamine (MEM++) in T175 flask
and maintained in 37 °C with 5% CO2 during the experiment. For
starvation, the medium was aspired and exchanged to fresh MEM++
supplemented with 30mM sterile 2-DG. For mitochondrial isolation we
used the cell homogenizer (Isobiotec, Germany) combined with 1mL
Glas syringes (Hamilton, USA) as described in Schmitt et al. [36]. Cells
were trypsinized and separated with syringe before homogenization. All
steps were performed on ice, the Isolation buffer was freshly prepared,
and all materials used were pre-cooled before each isolation. For HeLa
cells, the 6mm Tungsten carbide ball was used. Isolation buffer:
300mM Sucrose, 5 mM TES, 200 μM EGTA, pH should be adjusted with
KOH to 7.2. Protein concentration was determined via the Bradford
method using BSA as a standard. 50 μg protein were loaded per pocket.
Mitochondria were further processed in the presence of Digitonin
6 g/g Mitochondria [37]. Dimers of ATP synthase were resolved by
mean of high resolution Blue Native electrophoresis as described in
Witting et al. 2007 [38]. After separation on a 3–13% gel, the proteins
were electro-blotted onto Hybond-P-polyvinylidene fluoride (PVDF)
membranes (GE Healthcare) and immune-blotted with a primary anti-
body against subunit β of ATP synthase (Abcam 14730, mouse mono-
clonal). The secondary antibody was anti-mouse dylight 800 from
Rockland (610145002) and the signal detected using the Odyssey® In-
frared Imaging System (Li-COR bioscience). The densito-metric analysis
of the ratio between monomer and dimer of ATP synthase was per-
formed using Gel Eval™ software.
2.13. Western blotting
Cells were washed twice in PBS and extracted in sample buffer.
Depending on the confluency, 50 μL to 150 μL of SDS sample buffer was
added to each well (0.83% SDS; 6.25mM TRIS; 7.25% Glycerine;
0.0083% MercaptoEtOH; 0.01% Bromphenol blue) plus 0.1 μL
Benzonase® nuclease was added to the reaction tubes. The solution was
incubated at RT for 10min. The extracted proteins were separated by
SDS-PAGE and then transferred onto a polyvinylidene difluoride
(PVDF) membranes by semi-dry blotting. Detection of OXPHOS com-
plexes was done with a total rodent OXPHOS antibody cocktail (Abcam,
Ab110413). Subunit β was detected with an anti-ATP5B antibody
(proteintech #17247-1-AP), VDAC with an anti-VDAC antibody (Cell
signalling #4661), subunit e with an anti-ATP5I antibody (abcam
#122241). For the detection of bands, enhanced chemiluminescent
substrate consisting of a 1:1 mix of Luminol/Enhancer & Peroxide so-
lution was used.
2.14. Statistical analysis
Statistical analysis was performed using OriginPro version 9.6, 2019
(OriginLab Cooperation, Northhampton, MA). Student's t-test or
ANOVA was used with subsequent post hoc test (Scheffé-Test) or
pairwise comparisons if applicable (as indicated). For the calculation of
the ratio dimer/monomer (k=D /M) the ratio k was treated as a
function of two variables k (D, M). According to the error propagation
law of Gauss, the partial derivative of each variable must first be formed
from this function. Partial derivation to D means, for example, that the
function is differentiated to D and M is regarded as a constant. For the
calculated value k, the error σ is obtained according to:
= +1
M
D
M
2
D
2
2
2
M
2
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3. Results
3.1. 2-DG-caused HK inhibition leads to decreased glycolytic but increased
mitochondrial ATP synthesis rates
First, we investigated the effect of glycolysis inhibition on mi-
tochondrial oxidative phosphorylation (OXPHOS) in mammalian cer-
vical carcinoma cells (HeLa). HeLa cells are metabolically flexible and
thus a suitable model system [39]. The cells were cultivated with quasi
physiological concentrations of glucose (5.6mM) for several passages.
The inhibition of glycolysis was initiated by the addition of 2-Deoxy-D-
glucose (2-DG) in 5-fold excess (30mM) to the carbon source glucose
(5.6 mM) for up to 5 h. The mitochondrial respiratory function and
aerobic glycolysis were then analyzed with an extracellular metabolic
flux analyzer (Agilent/Seahorse). Although 2-DG was present all the
time, we found a time-dependent inhibitory effect on respiration that
was strongest in the first hour. 30min after addition of 2-DG, respira-
tion, measured as oxygen consumption rates (OCR) were reduced to
63%, but recovered to 75% in the next 30min and then showed a
continuous decrease (Fig. 1A). The decline was stronger than in the
control without 2-DG. In parallel, the extracellular acidification rate
(ECAR) as a measure of glycolysis, was recorded. The decrease in ECAR
was also strongest in the first 30–60min after 2-DG addition (Fig. 1B).
In the control, ECAR finally increased in response to rotenone and an-
timycin A, suggesting that extracellular acidification was mainly caused
by glycolysis and not by TCA cycle activity [40]. This was not the case
for the 2-DG probe, suggesting TCA cycle activity instead of glycolytic
activity under inhibitory conditions. Next, the mitochondrial stress test
was performed. The maximum respiration was measured in the pre-
sence of an uncoupler, here trifluoromethoxycarbonyl cyanide phe-
nylhydrazoneane (FCCP), after complex V inhibition with Oligomycin
(Fig. 1C). In the time period measured (0.5 h–5 h after initial addition of
2-DG), maximal respiration and spare capacity were reduced (Fig. 1D,
E). If 2-DG containing medium was replaced by standard medium for
another 2 h after 3 h incubation (=recover), a restoration of maximal
respiration to>90% of the control state was observed. The coupling
efficiency was not affected by 2-DG treatment. For metabolic pheno-
typing, the OCR/ECAR ratio was plotted and revealed a decrease of the
extracellular acidification rate as measure for glycolysis due to 2-DG
inhibition and as well as attenuation of respiration (Fig. 1F). The fact
that there were only slight differences in OCR between 0.5 h and 5 h
indicates the use of a different fuel for respiration. In a fuel test, glu-
cose, glutamine and fatty acids were added in combination with in-
hibitors for the different catabolic pathways (UK5099 for glycolysis;
etomoxir for FA oxidation and BPTES for glutamine conversion to
glutamate). The result shows that mitochondria became more depen-
dent on glutamine metabolism after glycolysis inhibition, whereas fatty
acids were apparently not used as an alternative energy source during
measurements (Fig. 1G). This is in accordance to the increased TCA
cycle activity observed before (Fig. 1B). To test for ATP synthesis, we
included an assay to determine mitochondrial versus glycolytic ATP
synthesis as recently established [41]. It revealed that mitochondrial
ATP production was increased during 2-DG treatment, while glycolytic
ATP production was significantly reduced (Fig. 1H). Notably, 2-DG
treatment did not cause a reduction in cell number (Fig. 1I). Next, we
determined the cytosolic ATP levels with a genetically encoded fluor-
escence probe known as ATeam. ATeams consist of the ATP-binding
subunit ε of a Bacillus sp., which is located between a fluorescent donor
and an acceptor protein [28,42]. After ATP-binding, conformational
changes increase Förster resonance energy transfer (FRET) and shorten
the fluorescence lifetime of the donor. We exchanged the donor for the
fluorescence protein Clover, and the acceptor for mRuby2, which re-
sulted in a Clover-SU-ε-mRuby2 ATeam construct. To monitor cytosolic
ATP changes, the fluorescence lifetime of the donor was recorded by
fluorescence lifetime imaging microscopy (FLIM). The data show that
the cellular ATP level decreased significantly between 0.5 and 1.5 h of
glycolysis inhibition (Fig. 1K). After 5 h the ATP values had risen again.
Although 2-DG was still present, this was not reflected in the glycolytic
ATP production rate values, (Fig. 1H).
3.2. The mitochondrial membrane potential is reduced during the
attenuation of respiration due to ongoing ATP synthesis
The active complexes I, III and IV pump protons into the intra
cristae space and generate an electrochemical gradient or membrane
potential (ΔΨm). We asked how the decrease in respiratory activity
following glycolysis inhibition affected ΔΨm. We used tetra-
methylrhodaminethyl ester (TMRE) to measure ΔΨm under normal
conditions and during inhibition of glycolysis and respiration. TMRE is
distributed in active mitochondria according to the Nernst equation and
in dependence on ΔΨm. An increase in TMRE fluorescence suggests an
increased electrochemical gradient or ΔΨm. By means of fluorescence
microscopy we determined the mean intensity of TMRE stained mi-
tochondria in single cells and normalized the signal on the
MitoTracker™Green signal, which is a mitochondrial mass indicator
[43]. To check the contribution of ATP synthase/ATPase to the ΔΨm,
oligomycin was added after taking a first round of images (Fig. 1L).
Oligomycin treatment resulted in increased ΔΨm, as expected when
ATP synthesis was performed before inhibition. We found that 2-DG
treatment generally resulted in reduced membrane potential with the
Fig. 1. Effect of glycolysis inhibition on mitochondrial respiration and physiology. (A–B) Mitochondrial oxygen consumption rates (OCR) and extracellular acid-
ification rates (ECAR) when inhibiting glycolysis with 2-DG over an extended period of time (N=2). (A) Effect of 2-DG-induced inhibition of glycolysis on oxygen
consumption rate. After 6 h rotenone and antimycin A (Rot: 0.5 μM; AA: 0.5 μM) were added. (B) Parallel determination of ECAR under the same conditions. (C) OCR
of HeLa cells under normal conditions (0 h, dark grey), 0.5 h (red) 1.5 h (orange), 3 h (yellow), 5 h (green) after 2-DG application and after recovery (=3 h 2-DG
followed by 2 h normal medium, blue) (N=3 independent experiments). Time point 5 h is not shown here. After basal respiration monitoring, oligomycin (1 μM),
uncoupler FCCP (trifluoromethoxy carbonylcyanide phenylhydrazone; 0.5 μM), rotenone and antimycin A (Rot, 0.5 μM; AA, 0.5 μM) were added at the indicated
times to determine ATP linked respiration, maximum respiration and OXPHOS specific oxygen consumption, respectively. (D) OCR results for all time points
including recovery conditions. Statistics were performed on means. (E) Spare capacity and coupling during 2-DG treatment (both in %). Statistics were performed on
means. (F) Ratio of oxygen consumption (OCR) to extracellular acidification rate (ECAR) for metabolic phenotyping. (G) Fuel dependency change under 2-DG
induced starvation. GLC: glucose, GLN: glutamine, FA: fatty acids (N=3). 2-DG inhibition induces increased glutamine metabolism after 0.5 h. Statistics were
performed on means; One Way ANOVA with post hoc Fisher LSD. (H) Dissection of glycolytic and mitochondrial ATP production rates. (I) 2-DG inhibition does not
affect the cell number during the measurement time. Fluorescently labeled nuclei from images captured by Cytation 1 were counted. (K) Relative changes in cytosolic
ATP levels determined by a modified ATeam, a FRET sensor for ATP [29] (N=2). (L) Effect of 2-DG and oligomycin on mitochondrial membrane potential (ΔΨm),
mass and morphology. TMRE (tetramethylrhodaminethyl ester, 7 nM) was used as ΔΨm sensitive dye and MitoTracker™Green (MTG, 100 nM) as mitochondrial mass
indicator [43]. (M) Effect of ATP synthase inhibition by oligomycin and ATPase inhibition by BMS-199264 during 2-DG treatment on ΔΨm. Oligomycin (1 μM), BMS
(5 μM), 2-DG (30mM), medium glucose (5.6mM). Box and whisker plots: The boxes represent the 25th to 75th percentiles. The vertical lines in the boxes represent
the median values, while the square symbols in the boxes represent the respective mean values. The minimum and maximum values are marked with x. Statistics: One
Way ANOVA with post hoc Tukey test and Students t-test for pairwise comparison. ⁎P≤0.05; ⁎⁎P≤0.01; ⁎⁎⁎P≤0.001. (N) For determination of mitochondrial ROS,
cells stained with CellROX Deep Red were analyzed via flow cytometry analysis (left graph). Moreover, MitoTracker Red CM-H2XRos stained cells were analyzed
with a fluorescence microscope (right graph). Statistics: One Way ANOVA with post hoc Tukey test (if not stated otherwise) performed on single values (if not stated
otherwise). All measurements were performed at 37 °C. Scale bars: 10 μm (L).
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lowest level 1 h after first addition of 2-DG, but already 0.5 h after 2-DG
application, ΔΨm was decreased (P≤0.01). The ΔΨm recovered in the
next few hours despite the presence of 2-DG (Fig. 1M). The level of
respiratory complexes I, II and V did not change during 2-DG treatment,
but the core subunit I of complex IV displayed a lower signal in im-
mune-detection at time point 0.5 h (Fig. S1). Reduced complex IV ac-
tivity could also explain the increase in mitochondrial ROS increase
after 0.5 h 2-DG treatment (Fig. 1N), and would result in a decreased
ΔΨm. Except for 5 h 2-DG treatment in the presence of oligomycin, the
ΔΨm was always significantly higher than with 2-DG alone, indicating
that ATP synthesis driven by the proton motive force was performed
during the treatment with 2-DG. We next tested the effect of the ATPase
specific inhibitor BMS-199264 [44] under control conditions. While the
oligomycin treatment increased the ΔΨm, the BMS-199264 treatment
significantly decreased the ΔΨm (P≤0.001). This would mean that
ATP hydrolysis in the absence of the inhibitor contributes to ΔΨm and is
stopped in the presence of BMS-199264. Accordingly, the decrease in
ΔΨm during 0.5-1.5 h 2-DG treatment might also be explained by in-
hibition of ATP hydrolysis. Mitochondrial morphology was not sig-
nificantly affected by 2-DG treatment (Figs. S2, S3).
3.3. Ultrastructural analysis of mitochondria
It has been reported that cristae narrow in response to starvation
[45]. In order to test whether glycolysis inhibition has the same effect,
TEM microscope images of mitochondria in a monolayer of cells in-
cubated with 2-DG were quantitatively analyzed in order to determine
the average mitochondrial width, the average cristae width, the number
of cristae per μm mitochondrial length, and the cristae shape (Fig. 2 and
Fig. S1). No significant differences were found when mitochondrial
diameter, and number of cristae per length unit of rod-shaped mi-
tochondria was analyzed in the time frame of 0–3 h after inhibition of
glycolysis. However, the cristae width narrowed (P=0.035) when
glycolysis was inhibited by 2-DG for 0.5 h (14.45 ± 2 nm) compared to
control (15.03 ± 3.6 nm). The effect was reversible and at 1.5 h after
2-DG there was no significant difference between control and 1.5 h 2-
DG treatment. So, similar to earlier studies, where cristae thinning was
observed under starvation [45], during short term slowdown of re-
spiration an intermediate decrease in the cristae width was detectable
(Fig. 2D).
3.4. Glycolysis inhibition alters the spatio-temporal organization of single
F1FO ATP synthase in the mitochondrial inner membrane
Following, we asked whether these slight variations in ultra-
structure and changes in complex V activity were correlated with a
different spatial organization of the enzyme. F1FO ATP synthase is
known to be involved in cristae-shaping [12]. Normally, the F1FO ATP
synthase is located at the tips and rims of cristae [15,16,46]. However,
it is not known how strict this localization/organization is and whether
it is influenced by different modes of complex V activity (e.g. ATP
synthesis vs. ATP hydrolysis). Since submitochondrial resolution was
required to monitor possible changes in the spatio-temporal organiza-
tion of complex V, a recently introduced fluorescence superresolution
technique - Tracking and Localization Microscopy (TALM) [19,47] -
was used to localize F1FO ATP synthase in sub-compartments of the
inner membrane. For fluorescence labeling, the HaloTag® was fused
with the C-terminus of complex V subunit γ as previously described
[47] and a stable cell line was generated expressing this construct.
Tagging of subunit γ at this position had no effect on respiratory
parameters in a stable transfected cell line (Fig. S4). For the specific
labeling, the Tetramethylrhodamine-HaloTag®-Ligand (TMRHTL) was
added for 20min as fluorescent substrate for the self-labeling HaloTag®.
Unbound TMRHTL substrate was then washed out. Due to the low
TMRHTL substrate concentrations (1 nM), the complex V labeling was
substoichiometric and individual molecules could be differentiated in
the flat, peripheral part of the cells in which the mitochondria form a
2D network [29]. In order to reduce the background fluorescence of
out-of-focus emitters, a highly inclined laminated optical sheet (HILO)
illumination was used for excitation [32]. For a comprehensive locali-
zation map of the complex V, 1000–3000 images were recorded (frame
rate 33 Hz). Fluorescence signals of individual molecules were fitted
Fig. 2. Ultrastructural analysis of mitochondria from glycolytic and glycolysis inhibited cells. (A) Transmission electron microscopy (TEM) images of single mi-
tochondria at different time points after 2-DG application and metabolic switch. (B) Average mitochondrial width (N=2 independent specimen; n=57 (0 h), n=40
(30min), n=40 (1.5 h), n=36 (3–5 h) mitochondria). (C) Average cristae width (n=224 cristae, 0 h; n=288 cristae, 0.5 h; n=290 cristae, 1.5 h; n=112 cristae,
3 h), (D) Cristae per length of mitochondrion (μm−1) (n=26, 0 h; n=13, 0.5 h; n=19, 1.5 h; n=15, 3 h). Scale bars: 0.3 μm (A). ANOVA test, P≤0.001⁎⁎⁎.
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with a 2D Gaussian distribution using a calculated point spread func-
tion as reference to obtain the precise localization for all particles. In
this way, we produced localization maps for complex V at different
times after glycolysis inhibition (Fig. 3A). Under control conditions,
complex V showed a structured distribution along the longitudinal axis
of a mitochondrion (Fig. 3A, left panel). During the first 2 h of glyco-
lysis inhibition, the distribution profile changed to a more dispersed
one. 2.5 h after addition of 2-DG, a regular, striped distribution pattern
of the F1FO ATP synthase was visible again in certain areas of the mi-
tochondria (Fig. 3A, right panel, white arrowhead).
A change in the localization pattern must be associated with a dy-
namic rearrangement of the F1FO ATP synthase. To test this, the
dynamics of the fluorescence-labeled F1FO ATP synthase in mitochon-
dria in living cells was determined by single molecule tracking micro-
scopy. For this purpose, trajectories of the mobile F1FO ATP synthase
were generated: Localized particles in subsequent frames were linked if
they were found within a defined maximum distance and if they had the
same biophysical footprint (such as intensity). The multi-target tracer
(MTT) algorithm [48] was used to identify and connect particles. In-
dividual trajectories were colored in different colors (Fig. S5A, B). By
overlaying trajectories, which were color-coded according to their
temporal occurrence, it was possible to determine whether the mi-
tochondria had moved during the recording time. Data from moving
mitochondria have not been considered (Fig. S5C). The dynamics of the
Fig. 3. The localization and dynamics of ATP synthase and ATPase are different. (A) Effects of 2-DG (2-deoxyglucose) on the localization pattern of F1FO ATP
synthase at different times after 2-DG addition. Localization maps of the single F1FO ATP synthase in mitochondria resulting from the summation of up to 3000
images. The application of a Gaussian fit on the PSF of the single molecules resulted in point localized F1FO ATP synthase single molecules. Recording rate: 30 fps
(33 Hz). Point localizations are false color-coded in Hot. (B) Mobility of ATP synthase at different times after onset of glycolysis inhibition with 2-DG. The panels show
trajectory maps of the F1FO ATP synthase in individual mitochondria resulting from time series between 48 and 96 s (1600–3000 frames), see Movie S1, Movie S2 and
Movie S3 in supplementary information. Trajectories of the F1FO ATP synthase were generated by using the Multi-Target-Tracing-Tool (MTT). Every single trajectory
in one color. (C) Mean square displacement (MSD) diagram showing the linear increase of the MSD in short-term (200ms) diffusion times. (D) Complete MSD plots
covering mean square displacements in the range between 2 and 20 steps (600ms). (E) Diffusion coefficients and anomalous coefficients calculated from MSD/time
diagrams according to Eq. (2). Scale bar: 1 μm (A, B).
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fluorescent F1FO ATP synthase particles were recorded over a period of
32 s to 96 s (1000 to 3000 images; 33 Hz) at different times of glycolysis
inhibition (0 h, 0.5 h, 1.5 h and 2.5 h) and cumulative trajectory maps
were generated. The movement of complex V in tubular single mi-
tochondria is shown in Fig. 4B as a cumulative superposition of re-
corded trajectories for the times 0 h, 0.5 h and 2.5 h after 2-DG appli-
cation.
Under normal respiratory conditions, complex V predominatly
shows restricted movement in cristae, visible as orthogonal trajectories.
This has already been comprehensively analyzed earlier [19,49].
However, within 0.5 h after glycolysis inhibition, the trajectory pattern
of the F1FO-ATP synthase became more diffuse (Fig. 3B, middle panel).
After 2.5 h more orthogonal trajectories appeared again (arrowhead
Fig. 3B, right panel). In order to quantify this, mean square displace-
ment diagrams (MSD) were generated (Fig. S6). If only the short-term
diffusion (2–5 step sliding intervals) was analyzed, the MSD increased
linearly over time for all conditions and time points (Fig. 3C). However,
in the presence of 2-DG and glycolysis inhibition, MSD were lower,
suggesting reduced complex V movement. When the MSDs were re-
corded for 2–20 steps, the relation between MSD and time was no
longer linear but attenuated, indicating restricted or anomalous diffu-
sion (Fig. 3D). We then calculated the diffusion coefficients from the
MSD according to the formula (2) in section 2.10:
Individual MSD/time diagrams for the different time points of 2-DG
inhibition are shown in Fig. S6. The total number of trajectories ana-
lyzed per condition is listed in supplementary Table 1.
The calculated diffusion coefficients of complex V in normal cells
and in inhibited cells were clearly different and showed a decrease of
the average mobility in the latter (Fig. 3E). At the same time, the
coefficient α decreased, which correlated with an increased anomalous
diffusion. In order to dissect this in detail, we determined the direc-
tionality of movement of complex.
3.5. Mitochondrial ATPase has a different temporal footprint than ATP
synthase
As described earlier, mobile complex V in cristae has a preferred
direction of motion orthogonal to the longitudinal axis of the mi-
tochondria [19,]. This is related to the almost exclusive localization of
ATP synthase in cristae [49,51,52]. When glycolysis was inhibited and
ATPase activity reduced, this motion pattern was clearly changed
(Fig. 3B, middle panel). To dissect these changes in more detail, the
trajectory map of complex V in mitochondria of an exemplary cell was
divided into three areas (#1, blue frame; #2, orange frame; #3, green
frame) (Fig. 4A). In area #1 (0s –15 s), trajectories with long step
lengths indicate the presence of unrestricted mobile particles, moving
in all directions (marked with m). In the upper part, a trajectory of an
immobile molecule is shown (light blue), marked with I (Fig. 4B, left
Fig. 4. Quantification of the dynamics and directionality of F1FO ATP synthase. (A) Trajectory map of the F1FO ATP synthase in two mitochondria after 0.5 h
incubation with 2-DG. A cumulative image with trajectories from a 1605 image film lasting 48 s is displayed. (B) Detailed view of the individual trajectories from the
framed part #1 of (A), each image shows the trajectories of 500 subsequent images (15 s). m: unrestricted movement, o: Diffusion orthogonal to the longitudinal axis
of the mitochondrion, i: immobile molecules. Individual trajectories are displayed in different colors; only trajectories with a minimum duration of 180ms are
displayed. (C) Analysis of the step directions with respect to the longitudinal axis (± 180° and 0°) and the orthogonal axis (−90° and +90°) represented on a
graduated disk. The direction of the trajectories from the framed areas of interest #1, 2 and 3 of (B) are shown here in the degree window. For the determination of
directionality, 5 successive steps were integrated.
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panel, # frame 1). In the lower part, several particles showed an or-
thogonal direction of motion typical for diffusion in cristae membranes
(indicated as o). During the next 15 s, further free moving particles
appeared in the upper part (m), while orthogonally moving (o) and
immobile molecules (i) continued to dominate in the lower part (see
Fig. 4B, middle panel, frame #1). Between 30 s and 45 s, mainly or-
thogonal trajectories were registered in the lower part (Fig. 4B, right
panel, frame #1). Next, we quantified the motion in relation to the
longitudinal axis of the mitochondria. Therefore, the direction of the
successive steps of a moving single molecule was described by a vector.
The relative shares of direction were expressed in degree [°] and plotted
on a circular disc. The longitudinal axis of a mitochondrion was as-
signed as covering±180° and 0° and the orthogonal axis as −90° and
90°. First, the longitudinal axis of a mitochondrion was drawn manu-
ally. Curved mitochondria first required a linearization. For this pur-
pose, the longitudinal axis of a curved mitochondrion was stretched to
linearity in order to generate a transformation matrix (Fig. S7C). For the
vector analysis, the integrated change of direction between the first and
the fifth step was determined and then plotted on the directionality disk
(Fig. S7D). This analysis also made it possible to determine the diffusion
coefficients D for the movement along the longitudinal axis and in the
orthogonal direction independently of each other by generating sepa-
rate MSDs (Fig. S8). The derivation of diffusion coefficients in depen-
dence on time shows that the physical constraint imposed by the cristae
architecture reduces the mobility (lower Dorthog.) compared to move-
ment along the tubular shape of the IBM (Fig. S8E).
The directional analysis of the areas framed in Fig. 4A shows that in
the area #1 trajectories with orthogonal direction (−90° and 90°)
prevail. This indicates an organization in the cristae sheet. In contrast,
the trajectories in the areas #2 and #3 are different with a strong share
of steps in the longitudinal direction (Fig. 4C). This would be consistent,
for example, with the movement in the tubular IBM, since in a tubular
structure the longitudinal direction (± 180° and 0°) always prevails
due to geometric reasons. Moreover, confined longitudinal trajectories
can also represent dimeric complex V at cristae edges.
We next performed a global directionality analysis for the motion of
ATP synthase/hydrolase under all conditions. The respective trajectory
maps that were analyzed are shown in Fig. 5A. Already visible from the
maps is the distinct pattern at time point 0.5 h of 2-DG inhibition of
glycolysis and respiration corresponding with the metabolic switch. The
directionality was quantified as described and results are displayed on
directionality discs. As the distribution shows, orthogonal/perpendi-
cular movement dominated at 0 h (Fig. 5B). Between 0.5 h to 1.5 h after
2-DG induced enhanced ATP synthesis, the vector analysis of direc-
tionality suggests an increased share of longitudinal movement. After
2.5 h, corresponding with a recovery of mitochondrial physiology and
ATP hydrolase activity, the preferential movement of complex V re-
verted back to an orthogonal orientation. We then performed MSD
analysis in the short time range (2–5 frames) for longitudinal and or-
thogonal movement separately (Fig. 5C). During the first 0.5 h, MSDs in
the orthogonal direction was lower than mean square displacements in
the longitudinal direction. At 2.5 h, the MSD in longitudinal and or-
thogonal direction did not differ any more (Fig. 5C). The different
mobility behavior of ATP synthase and ATPase resulted in different
Fig. 5. The diffusion of F1FO ATP synthase in cristae is reduced when glycolysis is inhibited. (A) Exemplary cumulative trajectory maps of ATP synthase in mi-
tochondria at different times after starting glycolysis inhibition. Time 0.5–1.5 h corresponds to inhibition of ATPase activity. (B) Directionality of ATP synthase
movement in mitochondria shown in (A). (C) Mean square displacements (MSDs) for longitudinal and orthogonal movement at 0.5 h and 2.5 h 2-DG treatment. (D)
Diffusion coefficients D for longitudinal and orthogonal displacements at different time points. The ratio of the diffusion coefficients Dlongit./Dorthog. is plotted to
demonstrate the difference exemplary.
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diffusion coefficients D for longitudinal and orthogonal motion
(Fig. 5D). The diffusion in the orthogonal direction was lowest at 1 h to
1.5 h corresponding with decreased ATPase activity. The directionality
analysis of> 15,000 steps of ATP synthase/hydrolase in mitochondria
at different time points (N=2 independent assays) essentially con-
firmed the results (Fig. S9). The directional diagrams for the movement
of ATP synthase were similar before and after 2.5 h of glycolysis in-
hibition, while at 0.5 h–1.5 h (increased ATP synthase activity) the
amount of orthogonal traces was reduced. In our opinion, this clearly
indicates a change in the spatio-temporal organization of ATP synthase
compared to ATP hydrolase. It appears that the average mobility of
complex V in cristae decreased when ATP synthesis was.
3.6. ATP synthase dimers display lower mobility than the average pool of
ATP synthase
In order to dissect dimeric complex V by its tracking behavior, we
tagged complex V at SUg with the HaloTag for labeling. SUg is sug-
gested to trigger ATP synthase dimerization together with SUe [53,54].
Cells were transiently transfected with SUe-HaloTag and labeled with
0.5 nM TMRHTL. We recorded trajectories of ATP synthase labeled at
SUg and SUγ in direct comparison (Fig. 6A). The trajectory maps of
complex V in single mitochondria show a clear difference with more
molecules displaying shorter step length and a significantly lower mean
square displacement of complex V labeled at SUg (Fig. 6B). For long
range diffusion, we calculated DSUg = 0.054±0.039 [SD] µm/s and
DSUγ = 0.033±0.039 [SD] µm/s. While complex V labeled at SUγ does
not discriminate between monomers, dimers and oligomers and thus
represents the entire population, labeling SUg probably will mainly
discern dimeric and oligomeric complex V. Short range diffusion ana-
lysis revealed that, dimers/oligomers of complex V are almost immobile
(Dshort range=0.018±0.005 [SD] µm/s compared to Dshort
range=0.046± 0.002 [SD] µm/s for SUg), localized at the cristae rims.
3.7. Inhibition of ATPase activity results in decreased mobility of complex V
In order to test, whether inhibition of ATPase activity affects the
mobility of the enzyme, we inhibited ATPase activity with the specific
inhibitor BMS-199264 [44]. If inhibition of ATPase activity under 2-DG
conditions was the cause for the decrease in diffusion, we would also
expect a decrease in mobility upon BMS-199264 treatment. Thus, cells
expressing the Halo-Tagged SUγ of ATP synthase were exposed to 5 μM
BMS-199264. This treatment caused a decrease in the ΔΨm (Fig. 1M),
which can be explained if ATP synthesis activity continued while AT-
Pase activity stopped. Indeed, we found decreased mobility of ATP
synthase when cells were incubated with BMS-199264 alone or to-
gether with 2-DG for 0.5 h (Fig. 7A). In parallel, a significant fraction of
quasi immobile particles appeared in the trajectory map (Fig. 7B, pink
arrowheads, right panel). Thus, inhibition of ATPase activity obviously
decreases the overall mobility of the enzyme. The localization map
reminds of the map of SUg (Fig. 6A).
3.8. Knockdown of inhibitory factor 1 IF1 results in an increase of complex
V mobility under normal and 2-DG conditions
We next asked, how ablation of inhibitory factor 1 (IF1) would
impact on the mobility of ATP synthase. IF1 binds to ATP synthase
dimers in the groove between α-helices of subunits α and β in the F1
head [55] and likely is involved in dimer/oligomer formation [56]. It
can be expected that knockdown of IF1 will result in increased ATP
hydrolysis, resulting in increased mobility of the enzyme. If the hy-
pothesis is correct that cells treated with 2-DG are IF1-blocked and
possess more oligomeric ATPase, in the absence of IF1 the mobility of
the overall complex V population should increase. We first generated
IF1-KO knockout cells by the CRISPR/Cas9 technology. Puromycin-re-
sistant clones were subjected to immunoblot analysis to verify knock-
out of the target gene (Fig. 8A). Four knockout clones were identified,
tracking studies were continued with clone #8. IF1-KO cells were
Fig. 6. Dimers of complex V display a very low mobility. (A) Trajectory maps of ATP synthase labeled at subunits γ and g in single mitochondria. The grey line was
drawn to indicate the mitochondria. Lines in color represent individual trajectories of single molecules. (B) Step length histograms and means square displacements
(MSD) are plotted. The MSD of the long range diffusion was fitted assuming anomalous diffusion (α= 0.069 for CV SU γ and 0.042 for CV SU g). For subunit γ labeled
ATP synthase, 12,277 trajectories were analyzed, for subunit g 22,811 trajectories.
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transiently transfected with CV-SU γ-Halo Tag, labeled with TMRHTL
and imaged at a TIRF-fluorescence microscope. 4000 frames per region
of interest were recorded with a frame rate of 32ms/frame. The fol-
lowing conditions were compared: control cells with glucose supply
(ctrl.), IF1-KO cells and IF1-KO cells treated with 2-DG (30mM for
0.5 h). The mobility of ATP synthase was determined with the MTT
tracker and the cumulative probability of the diffusion coefficients D
plotted (Fig. 8B). The peaks from left to right indicate ctrl., IF1-KO and
IF1-KO+2-DG conditions. The corresponding median D were then
plotted for comparison. Clearly, ATP synthase in IF1-KO cells displayed
a higher mobility than in control cells. This is expected, either when
more complex V monomers are present, respectively less complex oli-
gomers and/or ATPase activity is increased, according to our hypoth-
esis. Interestingly, 2-DG treatment for 0.5 h here further resulted in
increased mobility of complex V. We next analyzed the changes in ATP
synthase monomers, dimers and oligomers under the different condi-
tions.
3.9. Glycolytic inhibition results in a higher proportion of dimer-bound IF1
So far, our data suggested that the spatio-temporal re-organization
of complex V observed under inhibitory conditions is due to bioener-
getic changes in combination with changes in the molecular assembly.
Therefore, we determined whether the amount of subunit e, which is
known to contribute to dimerization of the complex V [57,58] was
changed during 2-DG treatment (ATP hydrolyzing conditions). We
compared levels of SUe with levels of SUβ. VDAC, an outer membrane
protein, was analyzed as a loading control. At 0.5 h, the level of SUe
was significantly (P=0.0077) reduced relative to the level of VDAC
after inhibition of glycolysis (Fig. 9A). In parallel, levels of subunit β
were determined. After 3 h, the relative protein level of complex V
appeared to be decreased (N=5, normalization on VDAC), however,
this was not confirmed in a different batch of experiments (Fig. S1).
When SUe was related to SUβ, the lowest ratio of SUe/SUβ was ob-
served at time point 0.5 h after inhibition of glycolysis.
To complement the results, we performed BN-PAGE to separate
oligomers, dimers and monomers of complex V at the different time
points after glycolysis inhibition. We found a relative decrease of di-
mers compared to monomers after 0.5 h of 2-DG treatment (Fig. 9B).
Oligomers apparently decreased between 0.5 h and 1.5 h after glyco-
lysis inhibition, but quantification was difficult (Fig. S10A). Next, we
tested, whether IF1, the inhibitory factor 1 of ATPase which is upre-
gulated in cancer cells [59], would bind to monomers and dimers
during the inhibition of glycolysis. This was indeed the case, we found
IF1 associated with monomeric and dimeric ATP synthase. Binding of
IF1 obviously is not exclusive to dimers. We then normalized the
Fig. 7. Inhibition of ATP hydrolysis activity results in decreased mobility of the ATP synthase population. (A) Histogram of diffusion coefficients for ATP synthase
under control conditions (5.6mM Glucose, no inhibition), in the presence of BMS-199264 (5 μM) and BMS-199264 treated in addition with 2-DG for 0.5 h. The
cumulative probabilities are plotted. Peaks from left to right: BMS+2-DG, BMS. Data from N=3 biological replicates. In the right graph, the median diffusion
coefficients are plotted. Numbers at the top of the columns indicate the number of analyzed trajectories. No errors are shown, since all trajectories (N=3 biological
replicates, > 20 cells) were analyzed in a batch procedure. (B) Trajectory map of mitochondria from an BMS treated cells and a BMS plus 2-DG treated cell, both 0.5 h
after application of the inhibitors. Frame rate 32ms, 4000 frames in total recorded, superimposition of all trajectories during measurement. Red: early trajectories
(frames 0–500), dark blue: late trajectories (frames 3500–4000).
K. Salewskij, et al. BBA - Bioenergetics 1861 (2020) 148091
12
calculated IF1 dimer/monomer ratio to the SUß dimer/monomer ratio.
The proportion of IF1 bound to dimers tended to increase relative to the
binding to monomers (Fig. 9B, right panel). Unfortunately, we could
not quantify changes in IF1 binding to the oligomeric complex V.
Our data suggest that glycolysis inhibition was accompanied by a
relative increase in the ratio of dimers/monomers that have bound IF1.
4. Discussion
The aim of this study was to check if the activity mode of mi-
tochondrial complex V, either ATP synthesis or ATP hydrolysis, is
associated with a specific spatio-temporal organization. Complex V of
oxidative phosphorylation was suggested to work as an ATP synthase
under physiological conditions, but under certain circumstances, e.g.
under ischemic or in cancer cells, it can function as an ATPase. To alter
complex V activity, we decided to inhibit glycolysis with 2-DG treat-
ment. As recently demonstrated, the inhibition of HK by 2-DG had a
strong and fast effect on mitochondrial ATP metabolism [42]. Also, one
advantage of this strategy was that respiration and ATP synthase were
not directly inhibited. Our measurements suggest that before 2-DG
administration a subpopulation of the complex V worked in reverse
mode. However, most surprisingly, mitochondrial ATP synthesis took
Fig. 8. ATP synthase mobility increases in 2-DG-treated IF1-KO cells. (A) Candidate IF1 knock-out clones of human cervical carcinoma cells were subjected to
immunoblot analysis with antibodies against IF1 and the mitochondrial marker protein VDAC. (B) Histogram of diffusion coefficients for ATP synthase under control
conditions (5.6 mM Glucose, no inhibition), in IF1-KO cells and in IF1-KO cells treated with 2-DG for 0.5 h. The cumulative probabilities are plotted. Peaks from left
to right: ctrl., IF1-KO, IF1-KO+2-DG. Boxes show the number of trajectories analyzed, and the statistical values (minimal D, maximal D, median, iqr: interquartile
range). Data from N=3 biological replicates. In the right graph, the diffusion coefficients are plotted. Numbers at the top of the columns indicate the number of
analyzed trajectories. No errors are shown, since all trajectories (N=3 biological replicates,> 20 cells) were analyzed in a batch procedure. (C) Trajectory map of
mitochondria from an IF1-KO cell treated with 2-DG. Frame rate 32ms, 4000 frames. Red: early trajectories (frames 0–500), dark blue: late trajectories (frames
3500–4000).
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place at the same time and continued during 2-DG inhibition as the
oligomycin effect suggests. Indeed, a similar transient increase of ma-
trix ATP levels upon 2-DG induced glucose deprivation was observed
earlier [42], followed by ATP decrease. During 2-DG treatment, the
mitochondrial membrane potential decreased, probably due to reduced
proton pumping. BMS-199264, an ATP hydrolase inhibitor, also de-
creased ΔΨm, suggesting that ATP hydrolysis activity was present be-
fore. Based on this data we suggest that two populations of complex V
with different function can be present at the same time, probably in
different sub-compartments: ATPase in the cristae sheet and ATP syn-
thase in more confined (cristae edges). Reverse proton pumping by ATP
hydrolysis function could be physiologically useful to provide a mem-
brane potential, e.g. for import processes [60].
Because mitochondria switched to another fuel source, the effects of
glucose depletion on ATP synthase/hydrolase were only short-term (0.5
to 1.5 h) and reversible. This reversibility enabled us to study the effects
of the induced shift on the organization of complex V. We determined
the spatio-temporal organization of complex V during the time window
for which we had evidence of altered ATPase activity and compared it
with the conditions in which ATP hydrolysis was blocked or released.
To block ATPase activity, we used the inhibitor BMS-199264 [44] and
to study the effect of a release of inhibition of ATPase, we used an IF1-
KO cell line. IF1, the inhibitor factor 1 is the physiological master
regulator of ATPase activity [56]. It is widely accepted that IF1 blocks
the hydrolysis function [61] but more recent data also suggest an in-
hibitory effect on the ATP synthesis mode [59]. A microscopy method
based on single molecule tracking and localization [19] was used to
dissect the organization of ATP synthase molecules in mitochondria in
situ and to generate detailed maps of the localization and dynamics of
complex V under different conditions. Under normal conditions, F1FO
ATP synthase is confined in cristae in terms of localization and mobility
[19,49,51,62], which manifests itself in restricted mobility. Significant
proportion of complex V displays orthogonal trajectories in the cristae
sheet, performing ATP hydrolysis. Here we report that this specific
spatio-temporal arrangement has changed with altered complex V ac-
tivity. A thorough analysis of the mobility patterns including the ana-
lysis of the directionality of the movement showed that the confined
mobile fraction of the ATP synthase in the cristae increased and the
orthogonal directional dependence was lost at the same time. In addi-
tion, we found a reduction in cristae width. A narrowing of the cristae
in response to starvation has been described earlier [13,45]. The ul-
trastructural changes under starvation were mainly attributed to the
changes in OPA1 levels, whereby the contribution of complex V was not
discussed [45]. However, no changes in OPA1 levels were reported for
2-DG-induced metabolic starvation [23], leading us to conclude that an
alteration in the complex V dimers/monomer ratio was mainly
Fig. 9. Glycolytic inhibition results in a relative higher proportion of dimer-bound IF1. (A) Relative protein levels of SUe of ATP synthase/complex V (AB: ATP5I) and
SU-β of ATP synthase (AB: ATP5B) and their ratio normalized to VDAC (AB: VDAC) at different times during glycolysis inhibition (N=5). SDS-PAGE with im-
munostaining as indicated. Statistics: ANOVA test, SD shown. (B) BN-PAGE separation of complex V oligomers, dimers, and monomers and detection of ATP
complexes by immunostaining with α-ATP5B (anti-SU-β) and with α-IF1 (anti-IF1). Abbreviations: o: oligomers d: dimers, m: monomers. Images are also shown in
inverse mode (right panel). No oligomers were detected with α-IF1. The dimer/monomer ratio was calculated for each gel and averaged (left and middle graph).
Right graph: Relative binding of IF1 to complex V dimers/monomers (normalized to the SU β signal). Mean values of three independent replicates were used.
Calculation of error propagation see statistics sections.
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responsible for the mild and reversible effect on cristae narrowing.
Since this would decrease the volume, more efficient coupling is ex-
pected [63]. In addition, we found a tendency of more IF1 binding to
complex V dimers under this condition. IF1 was shown to promote di-
merization of the mitochondrial F1FO ATP synthase [61]. In IF1-KO
cells, ATP synthase displayed a higher mobility, while in BMS-199264
treated cells (inhibition of ATP hydrolysis), the mobility decreased.
Together, this data support the hypothesis that ATPase activity is as-
sociated with a different localization and organizational state in the
inner mitochondrial membrane. We suggest that the assembly of ATP
synthase that is usually organized in a regular dimer/oligomer structure
at the cristae rims [16,52,64–66], thereby shaping the cristae curvature
[12,67,68], is associated with ATP synthase. Under 2-DG treatment, the
loss of orthogonal trajectories and the decrease of complex V mobility
in the cristae sheet suggests that immobile dimeric and oligomeric F1FO
ATP synthases remained. The observed cristae narrowing is in ac-
cordance with this, since a change of the cristae architecture is a fre-
quent outcome when the oligomerization of ATP synthase is altered due
to various conditions [13,14,17,63,69–71]. In this context, we provide
for the first time data on the dynamic spatio-temporal organization of
F1FO ATP synthase in living cells.
In summary, our observations suggest that the specific spatio-tem-
poral organization of complex V in subcompartments of the inner mi-
tochondrial membrane may be essential for its respective function,
namely either ATP synthesis or ATP hydrolysis. Obviously, complex V
displays a comparable dynamic organization as the respiratory com-
plexes which assemble into supercomplexes for functional adaptation
[72,73]. It can be speculated that the arrangement of the complex V
dimers in rows that form the cristae, which is obviously advantageous
for optimal function as ATP synthase [46], is not necessarily also the
typical arrangement for the ATPase function. However, to finally as-
certain this, the specific activity of F1FO ATP synthase would have to be
visualized with submitochondrial resolution in situ.
5. Conclusions
Mitochondrial F1FO ATP synthase has several functions: in ATP
synthesis, cristae shaping and possibly mitochondrial permeability. By
means of high-resolution localization and tracking of single molecules,
we have probed the current view of static F1FO ATP synthase organi-
zation as series of dimers aligned at the edges of cristae. Our results
rather suggest that subpopulations of complex V with different dis-
tribution and mobility exist in the inner membrane compartments.
Under normal respiratory conditions, complex V was mainly localized
in cristae, while under metabolic stress and nutrient deprivation with
decreased respiration this specific spatio-temporal pattern became in-
termediately blurred. We suggest that in addition to modification of the
metabolic setting, a shift in the ratio of oligomeric/dimeric F1FO ATP
synthase to monomeric forms is correlated with different distribution
and mobility in the inner mitochondrial membrane compartments. Such
dynamics would allow the simultaneous existence of ATP synthesis and
ATP hydrolysis function, but spatially separated.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbabio.2019.148091.
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